熱門資訊> 正文

Tango Therapeutics推出1亿美元的市场股票发行

2025-11-21 22:04

Tango Therapeutics(TNGX) 0

Tango Therapeutics (TNGX) entered a sales agreement with Leerink Partners to sell up to $100M of common stock through an at-the-market offering.
Leerink Partners will use commercially reasonable efforts to sell shares and will receive up to a 3% commission on gross proceeds.

More on Tango Therapeutics

Tango Therapeutics, Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers Transcript
Tango Therapeutics, Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers - Slideshow
Tango Therapeutics GAAP EPS of $0.14 beats by $0.15, revenue of $53.81M beats by $12.57M
Tango jumps on $225M funding and trial data for cancer drug
Seeking Alpha’s Quant Rating on Tango Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。